Butorphanol Tartrate

   
Google
 
Web NewDrugInformation.com

Butorphanol Tartrate


Drug - Butorphanol Tartrate
The trade name of the product as shown on the labeling.

Dosage - SPRAY, METERED; NASAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Butorphanol Tartrate
Multiple ingredients are in alphabetical order.

Strength - 1MG/SPRAY
The potency of the active ingredient(s), Butorphanol Tartrate. May repeat for multiple part products.

Applicant - NOVEX
The firm name holding legal responsibility for Butorphanol Tartrate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 075499
The FDA assigned number to Butorphanol Tartrate. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Butorphanol Tartrate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Dec 4, 2002
The date Butorphanol Tartrate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Butorphanol Tartrate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Butorphanol Tartrate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Novex Pharma
The full name of the firm holding legal responsibility for the new application of Butorphanol Tartrate.

Butorphanol Tartrate